| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 08/04/2015 | 20h27 | Business Wire | Keller Rohrback L.L.P. Announces Investigation Regarding Weight-Loss & Workout Supplements Containing Potentially Dangerous A... | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 28/04/2014 | 19h39 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 21/04/2014 | 18h18 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 17/04/2014 | 19h13 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 17/04/2014 | 19h10 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 17/04/2014 | 19h07 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 17/04/2014 | 18h57 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 17/04/2014 | 18h41 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 17/04/2014 | 16h27 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 17/04/2014 | 15h20 | Business Wire | Akorn Completes Acquisition of Hi-Tech Pharmacal | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 17/04/2014 | 15h06 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 15/04/2014 | 23h53 | PR Newswire (US) | Repligen Corporation Set to Join the S&P SmallCap 600 | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 15/04/2014 | 01h00 | Business Wire | Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 21/03/2014 | 21h46 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 20/03/2014 | 19h44 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 13/03/2014 | 21h22 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 12/03/2014 | 21h07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 11/03/2014 | 16h25 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 11/03/2014 | 12h00 | Business Wire | Hi-Tech Pharmacal Reports Sales of $59.9 Million for the Third Quarter Ended January 31, 2014 | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 10/03/2014 | 15h59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 12/02/2014 | 12h01 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 11/02/2014 | 12h02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 07/02/2014 | 18h59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 31/01/2014 | 15h36 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 23/01/2014 | 13h00 | Business Wire | Hi-Tech Pharmacal Receives Final Approval for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 26/12/2013 | 13h00 | Business Wire | Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 10/12/2013 | 13h00 | Business Wire | Hi-Tech Pharmacal Reports Sales of $58.6 million for the Second Quarter Ended October 31, 2013 | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 15/11/2013 | 13h11 | Dow Jones News | AQR Capital Management 3Q 13F: Largest Purchases -2- | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 15/11/2013 | 13h11 | Dow Jones News | AQR Capital Management 3Q 13F: Largest Purchases | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
| 15/11/2013 | 13h11 | Dow Jones News | AQR Capital Management 3Q 13F: Holdings As Of Sep -2- | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |